Cargando…
Molecular Hydrogen Inhibits Colorectal Cancer Growth via the AKT/SCD1 Signaling Pathway
OBJECTIVE: Molecular hydrogen (H(2)) has been considered a potential therapeutic target in many cancers. Therefore, we sought to assess the potential effect of H(2) on colorectal cancer (CRC) in this study. METHODS: The effect of H(2) on the proliferation and apoptosis of RKO, SW480, and HCT116 CRC...
Autores principales: | Zhang, Xiangyan, Tao, Geru, Zhao, Ya'nan, Xing, Sijie, Jiang, Jie, Liu, Boyan, Qin, Shucun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071919/ https://www.ncbi.nlm.nih.gov/pubmed/35528164 http://dx.doi.org/10.1155/2022/8024452 |
Ejemplares similares
-
PCK1 activates oncogenic autophagy via down-regulation Serine phosphorylation of UBAP2L and antagonizes colorectal cancer growth
por: Zhang, Xiangyan, et al.
Publicado: (2023) -
A strategy of local hydrogen capture and catalytic hydrogenation for enhanced therapy of chronic liver diseases
por: Tao, Geru, et al.
Publicado: (2023) -
Surf4 (Surfeit Locus Protein 4) Deficiency Reduces Intestinal Lipid Absorption and Secretion and Decreases Metabolism in Mice
por: Tao, Geru, et al.
Publicado: (2023) -
A randomized, placebo‐controlled clinical trial of hydrogen/oxygen inhalation for non‐alcoholic fatty liver disease
por: Tao, Geru, et al.
Publicado: (2022) -
Acid‐Degradable Hydrogen‐Generating Metal‐Organic Framework for Overcoming Cancer Resistance/Metastasis and Off‐Target Side Effects
por: Yao, Xianxian, et al.
Publicado: (2022)